Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

Ahead of RFK Jr.’s confirmation as head of the HHS, Dr. Dino Prato spoke about what is putting people’s health at risk — and ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Lenhoff, H. M., and Bovaird, J., Science, 130, 1474 (1959).

Chronic pain is a worldwide epidemic that disproportionately affects women. These surgeons have found innovative solutions - ...

Touch receptors are a subtype of sensory neuron that are located in the skin and possess specialized endings that respond to mechanical stimulation. As part of the somatosensory system ...

The ink of the cuttlefish could transform how sharks are deterred from hunting near swimmers, according to new research.

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

The company made an upfront payment and will provide success-based milestones and royalties in exchange for global rights.

Results from the company’s Talapro-2 trial saw a 38% reduction in the risk of death among HRR-mutated patients.